SCI Abstract

search
Asia–Pacific Real-World Evolocumab Use, LDL-C Reduction, Physician Goals, and Patient Perceptions: HALES Observational Study
Asia–Pacific Real-World Evolocumab Use, LDL-C Reduction, Physician Goals, and Patient Perceptions: HALES Observational Study
Real-world data are needed to understand the effectiveness of new therapeutic options for low-density lipoprotein choleste...
Expert Opinion on the Role of Sacubitril/Valsartan in the Management of Hypertension in India
Expert Opinion on the Role of Sacubitril/Valsartan in the Management of Hypertension in India
Hypertension, a key modifiable risk factor for cardiovascular diseases (CVD), significantly contributes to premature death...
Macitentan in Pulmonary Arterial Hypertension Due to Congenital Heart Disease (CHD-PAH): Real-World Evidence from the OPUS/OrPHeUS Studies
Macitentan in Pulmonary Arterial Hypertension Due to Congenital Heart Disease (CHD-PAH): Real-World Evidence from the OPUS/OrPHeUS Studies
Data on real-world clinical practice and outcomes of patients with pulmonary arterial hypertension (PAH) associated with c...
Atrial Fibrillation in Patients with Breast Cancer: A Literature Review
Atrial Fibrillation in Patients with Breast Cancer: A Literature Review
In addition to traditional risk factors, patients with breast cancer are at an increased risk of atrial fibrillation due t...
Prevalence, Patient Characteristics, and Treatment of Patients with Hypertrophic Cardiomyopathy: A Nationwide Payer Database Study
Prevalence, Patient Characteristics, and Treatment of Patients with Hypertrophic Cardiomyopathy: A Nationwide Payer Database Study
Data on the prevalence of hypertrophic cardiomyopathy (HCM), characteristics of patients with HCM, and treatment patterns ...
The Effect of Colchicine on Platelet Function Profiles in Patients with Stable Coronary Artery Disease: The ECLIPSE Pilot Study
The Effect of Colchicine on Platelet Function Profiles in Patients with Stable Coronary Artery Disease: The ECLIPSE Pilot Study
This prospective, single-arm pharmacodynamic study assessed the effect of colchicine (COLC) [Strides Pharma UK Ltd, Watfor...
Cardiovascular Outcomes of Early LDL-C Goal Achievement in Patients with Very-High-Risk ASCVD
Cardiovascular Outcomes of Early LDL-C Goal Achievement in Patients with Very-High-Risk ASCVD
Clinical trial evidence supports early low-density lipoprotein cholesterol (LDL-C) goal achievement in patients with ather...
Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis Care
Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis Care
Patients with amyloid transthyretin (ATTR) amyloidosis typically experience rapid disease progression, poor treatment outc...
Impella Versus VA-ECMO for Patients with Cardiogenic Shock: Preliminary Cost-Effectiveness Analysis in the Italian Context
Impella Versus VA-ECMO for Patients with Cardiogenic Shock: Preliminary Cost-Effectiveness Analysis in the Italian Context
Cardiogenic shock (CS) is a life-threatening failure of the heart to supply adequate blood, requiring immediate treatment....
Derivation of Stroke Volume from Pulmonary Artery Pressures
Derivation of Stroke Volume from Pulmonary Artery Pressures
Intermittent cardiac output (CO) studies using thermodilution are considered the gold standard. We have developed a stroke...
Broadening Perspectives of Artificial Intelligence in Echocardiography
Broadening Perspectives of Artificial Intelligence in Echocardiography
Echocardiography frequently serves as the first-line treatment of diagnostic imaging for several pathological entities in ...
Milvexian: An Oral, Bioavailable Factor XIa Inhibitor
Milvexian: An Oral, Bioavailable Factor XIa Inhibitor
Direct oral anticoagulants have a dose-dependent increased bleeding risk which limits use in certain populations. Studies ...
Narrative Review: Surgical and Hybrid Management of Atrial Fibrillation
Narrative Review: Surgical and Hybrid Management of Atrial Fibrillation
Although significant strides have been made in non-pharmacologic management of atrial fibrillation (AF), these treatments ...
Prognostic Implications of Coronary Artery Sclerosis in Troponin-Positive Patients with Non-Obstructive Coronary Arteries
Prognostic Implications of Coronary Artery Sclerosis in Troponin-Positive Patients with Non-Obstructive Coronary Arteries
Coronary sclerosis is a risk factor for the progression to obstructive coronary artery disease (CAD). However, understandi...
Implementing a Quality Intervention to Improve Confidence in Outpatient Venous Thromboembolism Management
Implementing a Quality Intervention to Improve Confidence in Outpatient Venous Thromboembolism Management
Guidelines recommend that patients with acute venous thromboembolism (VTE) represented by low-risk deep vein thrombosis (D...
All-Cause Mortality of Atrial Fibrillation and Heart Failure in the Same Patient: Does the Order Matter?
All-Cause Mortality of Atrial Fibrillation and Heart Failure in the Same Patient: Does the Order Matter?
Atrial fibrillation (AF) and heart failure (HF) often coexist due to the common elements of the pathomechanism they share....
Pharmacodynamic Comparison of Two Aspirin Formulations in the Caribbean: The ARC Study
Pharmacodynamic Comparison of Two Aspirin Formulations in the Caribbean: The ARC Study
This prospective, single-arm, crossover pharmacodynamic study assessed the effect of Bayer® low-dose enteric-coated a...
Recent Advances in Targeted Management of Inflammation In Atherosclerosis: A Narrative Review
Recent Advances in Targeted Management of Inflammation In Atherosclerosis: A Narrative Review
Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality despite effective low-de...
National Trends in Aspirin Use and Expenditures in the United States: Analysis of The Medical Expenditure Panel Survey 2000–2021
National Trends in Aspirin Use and Expenditures in the United States: Analysis of The Medical Expenditure Panel Survey 2000–2021
Since its invention in 1897, aspirin (ASA) has been the most widely used and cost-effective antiplatelet agent to prevent ...